ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) belongs to Healthcare sector. Its weekly performance is 0.50%. On last trading day company shares ended up $0.49. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) distance from 50-day simple moving average (SMA50) is 0.79%. On July 6, ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced the establishment of an agreement with Novella Clinical (Novella), to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies. The ICT-107 phase 3 trial will include approximately 120 clinical sites in the US, Europe and Canada, and will recruit about 400 patients with newly diagnosed glioblastoma. ImmunoCellular anticipates initiating the phase 3 trial in the fourth quarter of 2015.
CSX Corp. (NYSE:CSX) shares advanced 0.53% in last trading session and ended the day at $32.07. CSX Gross Margin is 69.10% and its return on assets is 7.20%. CSX Corp. (NYSE:CSX) quarterly performance is -2.93%. CSX Corp.’s second-quarter profit improved 5 percent on lower costs, even though the number of shipments the railroad delivered declined slightly. Shares rose as earnings beat analyst expectations, even though revenue dropped 6 percent to $3.06 billion, a steeper decline than Wall Street had expected. Total volume at CSX Corp., which operates more than 21,000 miles of track in 23 Eastern states and two Canadian provinces, slipped 1 percent. Coal revenue fell another 15 percent to $630 million.
On 14 July, Digital Realty Trust Inc. (NYSE:DLR) shares advanced 0.75% and was closed at $68.93. DLR EPS growth in last 5 year was 10.20%. Digital Realty Trust Inc. (NYSE:DLR) year to date (YTD) performance is 6.75%. Digital Realty Trust Inc. (NYSE:DLR), a provider of data center and colocation solutions, announced today that it has priced an underwritten registered public offering of 10.50 million shares of its common stock at a price of $68.00 per share, all of which are being offered in connection with the forward sale agreements.
Meritor, Inc. (NYSE:MTOR) ended the last trading day at $13.30. Company weekly volatility is calculated as 3.08% and price to cash ratio as 6.20. Meritor, Inc. (NYSE:MTOR) showed a weekly performance of 2.62%. On July 10, Meritor, Inc. (NYSE:MTOR) today announced that it has purchased the majority of the assets at the Sypris Solutions, Inc. manufacturing facility in Morganton, North Carolina.
Textron Inc. (NYSE:TXT) shares advanced 0.18% in last trading session and ended the day at $44.33. TXT Gross Margin is 17.90% and its return on assets is 4.30%. Textron Inc. (NYSE:TXT) quarterly performance is -2.76%. Bell Boeing, a strategic alliance between Bell Helicopter, a Textron (NYSE: TXT) company, and Boeing (NYSE: BA), was awarded a U.S. Navy contract today for five Bell Boeing V-22 Osprey tiltrotor aircraft to be delivered to Japan, marking the first sale of the aircraft through the U.S. government’s foreign military sales program.